Carolyn Bertozzi and Degrading Drugs for...

a16z General Partner Jorge Conde sits down with Moderna CEO Stéphane Bancel to discuss a major milestone for mRNA technology: positive Phase 3 results from Moderna and Merck’s individualized treatment for melanoma, after more than a decade of work on personalized cancer vaccines. ... Show More

Julie Yoo sits down with Dr. Suchi Saria, founder and CEO of Bayesian Health, to discuss the current state of clinical AI and what it takes to deploy AI systems in real-world healthcare settings. While much of the recent attention around AI has focused on copilots, chatbots, and ... Show More

Nicolás Abad, founder and CEO of Telepatía, joins a16z to discuss building AI-powered tools for healthcare in Latin America. Inspired by the loss of his father to a preventable medical error, Adbad set out to address one of the region’s most significant challenges: a shortage of ... Show More

"Pharmaceutical Breakthroughs: The Cutting Edge of Biotechnology" - In this episode, we dive deep into the revolutionary world of biotechnology and its transformative impact on pharmaceuticals. Discover how cutting-edge innovations are reshaping drug development, accelerating vac ... Show More

The rapidly evolving field of protein design is revealing solutions to some of the world’s greatest problems, whether it's blocking a virus, breaking down a pollutant or creating brand-new materials. In conversation with TED’s Whitney Pennington Rodgers, biochemist David Baker ex ... Show More

The rapidly evolving field of protein design is revealing solutions to some of the world’s greatest problems, whether it's blocking a virus, breaking down a pollutant or creating brand-new materials. In conversation with TED’s Whitney Pennington Rodgers, biochemist David Baker ex ... Show More

We look at a gene editing breakthrough, a new technique to correct genetic errors in sick patients. Roland speaks to Professor David Liu to learn about the base editing technology.Also, we look into the complex causes of last year's post-pandemic spike in child hepatitis. Profess ... Show More

Listen as two leading researchers at the cutting edge of computational biology explore breakthrough GPU accelerations that are changing how we understand life's molecular machinery. Chris Dallago, Research Lead at NVIDIA and Visiting Professor at Duke University, and Martin Stein ... Show More

<p>Can we make science as fast as software? </p><p>In this episode, Erik Torenberg talks with Patrick Hsu (cofounder of Arc Institute) and a16z general partner Jorge Conde about Arc’s “virtual cells” moonshot, which uses foundation models to simulate biology and guide experiments ... Show More

Founding story of Nautilus [1:43]Why was the Nautilus approach to proteomics a breakthrough? [6:12]Why a startup instead of academic research? [9:57]How to pick a good cofounder (it's not that different from choosing a spouse) [15:32]Advice for academic founders: how to work with ... Show More

<p>Two scientists realize that the very same AI technology they have developed to discover medicines for rare diseases can also discover the most potent chemical weapons known to humankind. Inadvertently opening the Pandora’s Box of WMDs. What should they do now?</p> <p><em>Speci ... Show More